Facile Generation of Potent Bispecific Fab via Sortase A and Click Chemistry for Cancer Immunotherapy
Bispecific antibodies (BsAbs) for T cell engagement have shown great promise in cancer immunotherapy, and their clinical applications have been proven in treating hematological malignance. Bispecific antibody binding fragment (BiFab) represents a promising platform for generating non-Fc bispecific a...
Main Authors: | Xuefei Bai, Wenhui Liu, Shijie Jin, Wenbin Zhao, Yingchun Xu, Zhan Zhou, Shuqing Chen, Liqiang Pan |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-09-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/13/18/4540 |
Similar Items
-
Site-specific PEGylation of an anti-CEA/CD3 bispecific antibody improves its antitumor efficacy
by: Pan H, et al.
Published: (2018-05-01) -
Bispecific antibodies with Fab-arms featuring exchanged antigen-binding constant domains
by: Filippo Benedetti, et al.
Published: (2021-07-01) -
Extending the in vivo Half-Life of Adalimumab Fab via Sortase A-Mediated Conjugation of Adalimumab Fab with Modified Fatty Acids
by: Qing-Bin Zhang, et al.
Published: (2020-12-01) -
Drugs of the Future - Bispecific Antibodies : An investigaion of future development needs
by: Svahn, Carl Fabian, et al.
Published: (2019) -
Greatest Hits—Innovative Technologies for High Throughput Identification of Bispecific Antibodies
by: Tim Hofmann, et al.
Published: (2020-09-01)